Photo of Rocio Garcia-Carbonero taken from consejosdetufarmaceutico.com
Aug 10, 2024, 13:59
New hope in treating advanced grade 3 Neuroendocrine Neoplasms – Garcia-Carbonero’s Lab
Garcia-Carbonero’s Lab shared a post on X:
“New hope in treating advanced grade 3 Neuroendocrine Neoplasms!
The NICE-NEC trial (GETNE-T1913) shows Nivolumab and platinum-doublet chemo can extend survival for over a third of patients.
Median OS: 13.9 months; 37.6% are long-term survivors.”
Source: Garcia-Carbonero’s Lab/X
Authors: Maria Carmen Riesco-Martinez, Jaume Capdevila, Vicente Alonso, Paula Jimenez-Fonseca, Alex Teule, Enrique Grande, Isabel Sevilla, Marta Benavent, Teresa Alonso-Gordoa, Ana Custodio, Beatriz Anton-Pascual, Jorge Hernando, Eduardo Polo, Oscar Alfredo Castillo-Trujillo, Arantza Lamas-Paz, Ana Teijo, Yolanda Rodriguez-Gil, Beatriz Soldevilla and Rocio Garcia-Carbonero.
Alex Teule
Ana Custodio
Ana Teijo
Arantza Lamas-Paz
Beatriz Anton-Pascual
Beatriz Soldevilla
cancer
Eduardo Polo
Enrique Grande
Garcia-Carbonero's Lab
Isabel Sevilla
Jaume Capdevila
Jorge Hernando
Maria Carmen Riesco-Martinez
Marta Benavent
Neuroendocrine Neoplasms
NICE-NEC trial
nivolumab
OncoDaily
Oncology
Oscar Alfredo Castillo-Trujillo
Paula Jimenez-Fonseca
Rocio Garcia-Carbonero
Teresa Alonso-Gordoa
Vicente Alonso
Yolanda Rodriguez-Gil
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 00:19
Nov 14, 2024, 00:02
Nov 13, 2024, 23:57
Nov 13, 2024, 23:54
Nov 13, 2024, 23:48
Nov 13, 2024, 23:46